3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Carcinoma, Renal Cell
73
Neoplasm Metastasis
30
Kidney Neoplasms
26
Neoplasms
19
Breast Neoplasms
14
Prostatic Neoplasms
12
Urinary Bladder Neoplasms
10
Melanoma
9
Gastrointestinal Stromal Tumors
9
Brain Neoplasms
9
Glioblastoma
8
Sarcoma
7
Carcinoma, Non-Small-Cell Lung
7
Liver Neoplasms
6
Carcinoma, Hepatocellular
6
Recurrence
5
Pancreatic Neoplasms
5
Ovarian Neoplasms
5
Esophageal Neoplasms
5
Colorectal Neoplasms
5
Thyroid Neoplasms
4
Solid Tumors
4
Osteosarcoma
4
Lung Neoplasms
4
Leukemia, Myeloid, Acute
4
Adenocarcinoma
4
Uveal Melanoma
3
Thymoma
3
Stomach Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Interventions
Mitotane
7
Cisplatin
6
pembrolizumab
5
Etoposide
3
Doxorubicin
3
camrelizumab
2
apatinib
2
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Cytoreduction Surgical Procedures
2
sodium thiosulfate
1
iodophenyl metomidate
1
fludarabine phosphate
1
dostarlimab
1
cemiplimab
1
cabozantinib
1
cabazitaxel
1
antineoplaston AS 2-1
1
antineoplaston A10
1
Suramin
1
Sunitinib
1
Streptozocin
1
Sorafenib
1
Radiation
1
Paclitaxel
1
Observation
1
Nivolumab
1
Megestrol Acetate
1
Lymph Node Excision
1
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Adrenocortical Carcinoma
×
Sunitinib
×
Clear all
NCT00453895
2019-01-31
SIRAC
University of Wuerzburg
Phase 2
Completed
39 enrolled
10 charts